期刊文献+

枸橼酸局部抗凝在危重患者血液滤过中的应用 被引量:16

Regional citrate anticoagulation for hemofiltration in critically ill patients
下载PDF
导出
摘要 相对于普通肝素的系统性抗凝,枸橼酸在血液净化中只产生局部抗凝作用。其具有良好的抗凝效果,延长滤器使用时间,减少出血风险及降低输血需求。枸橼酸局部抗凝在危重患者连续性肾脏替代治疗(CRRT)中的地位应得到重视。本文从作用机制、代谢、抗凝的优势及并发症方面介绍枸橼酸局部抗凝。 Compared with the systemic anticoagulation of unfractionated heparin, citrate provides regional anticoagulation of the circuit in blood purification. Citrate shows efficient anticoagulation effect and prolongs filter lifespan; it reduces the risk of bleeding and the need for blood transfusion. The role of regional citrate anticoagulation in critically ill patients with continuous renal replacement therapy (CRRT) will be more important. The mechanism, metabolism, advantages and complications of the regional citrate anticoagulation will be review in this paper.
出处 《中国急救医学》 CAS CSCD 北大核心 2016年第8期754-757,共4页 Chinese Journal of Critical Care Medicine
关键词 连续肾脏替代治疗(CRRT) 血液滤过 枸橼酸 抗凝 危重症 Continuous renalreplacement therapy (CRRT) Hemofiltration Citrate Anticoagulation Critically ill
  • 相关文献

参考文献19

  • 1Davenport A,Tolwani A. Citrate anticoagulation for continuous re- nal replacement therapy (CRRT) in patients with acute kidney in- jury admitted to the intensive care unit [ J ]. NDT Plus, 2009,2 (6): 439-447.
  • 2Bagshaw SM, Laupland KB, Boiteau PJ, et al. Is regional citrate superior to systemic heparin antieoagulation for continuous renal replacement therapy? A prospective observational study in an adult regional critical care system [J]. J Crit Care, 2005,20 (2): 155-161.
  • 3Sehilder L, Nurmohamed SA, Bosch FH, et al. Citrate antieoagula- tion versus systemic heparinisation in continuous venovenous he- mofihration in critically ill patients with acute kidney injury: a multi-center randomized clinical trial [J ]. Crit Care, 2014, 18 (4): 472.
  • 4Oudemans-van Straaten HM. Citrate anticoagulation for con- tinuous renal replacement therapy in the critically ill [J]. Blood Purif, 2010,29(2): 191-196.
  • 5Gattas D J, Rajbhandari D, Bradford C, et al. A Randomized Con- trolled Trial of Regional Citrate Versus Regional Heparin Anti- coagulation for Continuous Renal Replacement Therapy in Criti- cally Ill Aduhs[J]. Crit Care Med,2015,43(8):1622-1629.
  • 6James MF, Roche AM. Dose-response relationship between plas- nm ionized calcium concentration and thrombelastography [J]. J Cardiothorac Vase Anesth, 2004,18 (5) :581-586.
  • 7Zheng Y, Xu Z, Zhu Q, et al. Citrate Phammcokinetics in Critical- ly Ill Patients with Acute Kidney Injury [J]. PLoS One, 2013, 8 (6):e65 992.
  • 8Kranmr L, Bauer E, Joukhadar C, et al. Citrate pharmacokineties and metabolism in cirrhotic and noncirrhotie critically ill patients [J]. Crit Care Med ,2003,31 ( 10):2450-2455.
  • 9Sehultheiss C, Saugel B, Phillip V, et al. Continuous venovenous hemodialysis with regional citrate antieoagulation in patients with liver failure: a prospective observational study [J]. Crit Care, 2012,16(4):Rl62.
  • 10Mariano F, Morselli M, Bergamo D, et al. Blood and uhrafiltrate dosage of citrate as a useful and routine tool during continuous ve- novenous haemodiafihration in septic shock patients [J]. Nephrol Dial Transplant, 2011,26(12) :3882-3888.

同被引文献105

引证文献16

二级引证文献51

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部